GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cells

Omar Flores1, Kerry L Burnstein

  • 1Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, 1600 NW 10th Avenue, R-189, Room 6155 Rosenstiel Building, Miami, Florida 33136, USA.

Endocrinology
|August 27, 2010
PubMed

Insights

1,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by regulating GADD45γ. This vitamin D metabolite

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] is known to inhibit prostate cancer cell proliferation by affecting cell cycle progression.
  • The precise mechanisms underlying 1,25-(OH)2D3's antiproliferative effects, while requiring the vitamin D receptor, are not fully understood.
  • A 1,25-(OH)2D3-resistant prostate cancer cell line (LNCaP) was developed, retaining vitamin D receptors but lacking growth inhibition by 1,25-(OH)2D3.

Purpose of the Study:

  • To elucidate the molecular mechanisms of 1,25-(OH)2D3's antiproliferative effects in prostate cancer cells.
  • To identify novel genes regulated by 1,25-(OH)2D3 in prostate cancer.
  • To establish the role of identified genes, specifically GADD45γ and MIG6, in vitamin D-mediated growth inhibition.

Main Methods:

  • Gene expression profiling was performed on LNCaP and 1,25-(OH)2D3-resistant cells to identify differentially expressed genes.
  • The function of identified genes (GADD45γ and MIG6) was investigated through ectopic expression in prostate cancer cell lines (LNCaP, ALVA31).
  • Cell cycle progression and proliferation were analyzed following gene manipulation and 1,25-(OH)2D3 treatment.

Main Results:

  • Gene expression profiling identified two novel 1,25-(OH)2D3-inducible genes: GADD45γ and MIG6, in responsive LNCaP cells but not in resistant cells.
  • GADD45γ up-regulation correlated with 1,25-(OH)2D3-induced growth inhibition; ectopic GADD45γ expression caused G1 cell cycle arrest and proliferation inhibition.
  • 1,25-(OH)2D3-induced GADD45γ expression was independent of androgen receptor signaling, suggesting a distinct pathway for vitamin D-mediated growth inhibition.

Conclusions:

  • GADD45γ is identified as a novel 1,25-(OH)2D3-regulated gene that mediates growth inhibition in prostate cancer cells.
  • Ectopic expression of GADD45γ effectively inhibits prostate cancer cell proliferation and induces G1 cell cycle arrest, mimicking 1,25-(OH)2D3 effects.
  • The induction of GADD45γ by 1,25-(OH)2D3 presents a potential biomarker for therapeutic response in prostate cancer treatment.

Related Concept Videos

Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.